Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: Receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1

Immunology

Volumn 91, Issue 4, 1997, Pages 572-578

  Nashar, T O ^a   Hirst, T R ^a   Williams, N A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; ESCHERICHIA COLI ENTEROTOXIN; GANGLIOSIDE GM1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; ESCHERICHIA COLI; FEMALE; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030859151     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00291.x     Document Type: Article

References (28)

1. HIRST T.R. (1995) Bacterial toxins and virulence factors in disease. In: Handbook of natural toxins (eds J. Moss, B. Iglewski, M. Vaughan & A.T. Tu), Vol. 8, p. 123. Marcel Deckker Inc., New York.
2. Hol, W.G.J., SIXMA T.K. & MERRITT E.A. (1995) Structure and function of Escherichia coli heat-labile enterotoxin and cholera toxin B-pentamer. In: Handbook of natural toxins (eds J. Moss, B. Iglewski, M. Vaughan & A.T. Tu), Vol. 8, p. 185.
3. NASHAR T.O., AMIN T., MARCELLO A. & HIRST T.R. (1993) Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 11, 235.
4. NASHAR T.O. & HIRST T.R. (1995) Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB). Vaccine 13, 803.
5. ELSON C.O. & EALDING W. (1984) Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol 133, 2892.
6. LYCKE N. & HOLMGREN J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301.
7. JETBORN M., SEVENNERHOLM, A-M & HOLMGREN J. (1992) Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 10, 130.
8. + T cell dependent. Infect Immun 59, 3630.
9. LEWIS D.J.M., CASTELLO-BRANCO L.R.R., NOVOTNY P., DOUGAN G., POULTON T.A. & GRIFFIN G.E. (1993) Circulating cellular immune response to oral immunisation of humans with cholera toxin B-subunit. Vaccine. 11, 119.
10. WOOGEN S.D., EALDING W. & ELSON C.O. (1987) Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin. J Immunol 139, 3764.
11. ELSON C.O. & SOLOMON S. (1990) Activation of cholera toxin-specific T cells in vitro. Infect Immun 58, 3711.
12. FRANCIS M.L., RYAN J., JOBLING M.G., HOLMES R.K., MOSS J & MOND J.J. (1992) Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J Immunol 148 (1999).
13. ANASTASSIOU E.D., YAMADA H., FRANCIS M.L., MOND J.J. & TSOKOS G.C. (1990) Effects of cholera toxin on human B cells: Cholera toxin induces B cell surface DR expression while it inhibits anti-μ antibody-induced cell proliferation. J Immunol 145, 2375.
14. BROMANDER A., HOLMGREN J. & LYCKE N. (1991) Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol 146, 2908.
15. HIRABAYASHI Y., TAMURA S.I., SHIMADA K. & KURATA T. (1992) Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit. Immunology 75, 493.
16. NASHAR T.O., WEBB, H.M. EAGLESTONE S., WILLIAMS N.A. & HIRST T.R. (1996) Potent immunogenicity of the B-subunits of E. coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc Natl Acad Sci USA 93, 226.
17. + T lymphocytes. Int Immunol 8, 731.
18. AMIN T. & HIRST T.R. (1994) Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Prot Express Purif 5, 198.
19. WILLIAMS N.A., HILL T.J. & HOOPER D.C. (1991) Murine epidermal antigen presenting cells in primary and secondary T cell proliferative response to a soluble protein antigen. Immunology 72, 34.
20. HARPER H.M., COCHRANE L & WILLIAMS N.A. (1996) The role of small intestinal antigen presenting cells in the induction of T-cell reactivity to soluble protein antigens: association between aberrant presentation in the lamina propria and oral tolerance. Immunology 89, 449.
21. COOPER M.D., KEARNEY J.F., GATHINGS W.E. & LAWTON A.R. (1980) Effects of anti-Ig antibodies on the development and differentiation of B cells. Immunol Rev 52, 29.
22. NOELLE R., KRAMMER P.H., OHARA J. & VITETTA E.S. (1984) Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc Natl Acad Sci USA 81, 6149.
23. JENKINS M.K. & JOHNSON J.G. (1993) Molecules involved in T-cell costimulation. Curr Opin Immunol 5, 361.
24. CROFT M (1994) Activation of naive, memory and effector T cells. Curr Opin Immunol 6, 431.
25. LEDERMAN S., YELLIN M.J., COVEY L.R., CLEARY A.M., CALLARD R. & CHESS, L. (1993) Non-antigen signals for B-cell growth and differentiation to antibody secretion. Curr Opin Immunol 5, 439.
26. XU-AMANO J.C., JACSON R.J., FUJIHASHI K., KIYONO H., STAATS H. & MCGHEE J.R. (1994) Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12, 903.
27. WILSON A.D., BAILEY M., WILLIAMS N.A. & STOKES R. (1991) The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur J Immunol 21, 2333.
28. DUGAS B., PAUL-EUGENE N., GENOT E., MENCIA-HUERTA J.M., BRAQUET P. & KOLB J.P. (1991) Effect of bacterial toxins on human B cell activation. II. Mitogenic activity of the B subunit of cholera toxin. Eur J Immunol 21, 495.